Financials

  • Market Capitalization 491.08 M
  • Employee 281
  • Founded N/A
  • CEO N/A
  • Website www.cerus.com
  • Headquarter Delaware, United States
  • FIGI BBG000HBVZX8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-19.88
Price to sales ratio
265.32
Dividends per share
Dividend yield %

Cerus Corporation

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

Nouvelles